scispace - formally typeset
C

Carmelo Puglia

Researcher at University of Catania

Publications -  107
Citations -  4142

Carmelo Puglia is an academic researcher from University of Catania. The author has contributed to research in topics: Solid lipid nanoparticle & Skin erythema. The author has an hindex of 35, co-authored 100 publications receiving 3538 citations. Previous affiliations of Carmelo Puglia include Health Science University.

Papers
More filters
Journal ArticleDOI

Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.

TL;DR: Direct as well as indirect evidences corroborate the early reports on the usefulness of lipid nanoparticles as carriers for topical administration, stimulating new and deeper investigations in the field.
Journal ArticleDOI

Cubosome dispersions as delivery systems for percutaneous administration of indomethacin

TL;DR: Reflectance spectroscopy demonstrated that indomethacin incorporated into MO dispersions can be released in a prolonged fashion and can be proposed as nanoparticulate systems able to control the percutaneous absorption of indometHacin.
Journal ArticleDOI

Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals

TL;DR: Solid lipid nanoparticles and the newest nanostructured lipid carriers (NLC) show important advantages for dermal application of cosmetics and pharmaceuticals, and are able to enhance drug penetration into the skin, allowing increased targeting to the epidermis and consequently increasing treatment efficiency and reducing the systemic absorption of drugs and cosmetic actives.
Journal ArticleDOI

Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.

TL;DR: Indomethacin (IND)-loaded SLN and NLC were prepared and the organization and distribution of the different ingredients originating each type of nanoparticle system were studied by differential scanning calorimetry (DSC) technique.
Journal ArticleDOI

Protective effect of Capparis spinosa on chondrocytes.

TL;DR: It is observed that LECS was able to counteract the harmful effects induced by IL-1beta, and appeared to be greater than that elicited by indomethacin, which is usually employed in joint diseases.